Font Size:
a
A
A
Keyword [Newly diagnosed]
Result: 41 - 60 | Page: 3 of 10
41.
Curative Effects Observation Of Continuous Subcutaneous Insulin Infusion And Multisubcutaneous Insulin Injection In Newly Diagnosed Type 2 Diabetic Patients
42.
Study On The Change Of Chemerin Expression In 3T3-L1 Preadipocyte Differentiation And The Plasma Chemerin Levels In Newly Diagnosed Patients With Type 2 Diabetes Mellitus
43.
The Level Of Fasting Serum Apelin And The Relationship Of Fasting Serum Apelin And Other Factors In Newly Diagnosed Type 2 Diabetes Patients
44.
Expression And Significance Of Beta-catenin And CyclinD1 In Newly Diagnosed Acute Myeloid Leukemia Patients
45.
Advanced Glycation Index And Atherosclerosis In Newly Diagnosed Type 2 Diabetes
46.
Study Of The Relationship Between Serum Total Bilirubin And Subclinical Atherosclerosis In Newly Diagnosed Type 2 Diabetes Patients
47.
Effects Of Intensive Insulin Therapy On Function Of Pancreatic β Cell In Type 2 Diabetes At Different Phages
48.
The Influencing Factors Of The Vascular Endothelial Injury In Newly Diagnosed Type 2 Diabetes And The Effect Of Transient Continuous Subcutaneous Insulin Infusion Therapy
49.
Effect Of Short-term CSâ…¡ Intensive Therapy On The Level Of GLP-1 In Newly Diagnosed Type 2 Diabetes
50.
Metformin In Therapy For Patients With Newly Diagnosed Type 2 Diabetes And Impaired Glucose Tolerance
51.
The Evaluation Of Body Iron Metabolism In Pre Diabetes And Newly-diagnosed Type 2 Diabetes And The Role In The Pathogenesis
52.
The Incidence Of Artery Atheromatous Plaques In Newly Diagnosed Type 2 Diabetic Patients And The Correlative Risk Factors
53.
Efficacy And Safety Of Standard Or Topiramate For Monotherapy In Patients With Newly Diagnosed Epilepsy
54.
The Effects Of Short-Term Intensive Insulin Therapy On HPA Axis Function In Newly-Diagnosed Type 2 Diabetic Patients
55.
Effects Of Decoction-Combined CSII Treatment On Patients With Newly Diagnosed Type 2 Diabetes Mellitus (Vital Qi And Yin Deficiency Syndrome)
56.
Levels Of Serum Pancreatic-derived Factor (PANDER) And Their Correlation With Islet β Cell Function In The Newly Diagnosed Type 2 Diabetes
57.
The Effect Of Repaglinide On β-cell Function Of Newly Diagnosed Type 2 Diabetes Mellitus Evaluated By True Insulin
58.
The Expression Of CD4~+ CD25~+ Foxp3~+ Treg In Newly Diagnosed Type 2 Diabetic Patients
59.
Islet β-cell Function And It's Relation To Amylin And Melatonin In Newly Diagnosed Elderly Diabetic Patients
60.
Relationship Between Plasma Omentin-1, Visfatin And Atherosclerosis In Newly Diagnosed Type 2 Diabetes Patients
<<First
<Prev
Next>
Last>>
Jump to